Short Interest in BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Rises By 881.9%

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNHGet Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 815 shares, a growth of 881.9% from the August 15th total of 83 shares. Based on an average daily trading volume, of 11,376 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are short sold.

BioForce Nanosciences Trading Up 23.8%

OTCMKTS BFNH traded up $1.68 during trading on Thursday, hitting $8.75. 52,018 shares of the company traded hands, compared to its average volume of 7,514. BioForce Nanosciences has a 12 month low of $0.18 and a 12 month high of $10.15. The business has a fifty day simple moving average of $2.76 and a 200 day simple moving average of $1.50. The company has a market capitalization of $333.11 million, a P/E ratio of 875.88 and a beta of -0.31.

BioForce Nanosciences (OTCMKTS:BFNHGet Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter.

About BioForce Nanosciences

(Get Free Report)

BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.

Further Reading

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.